Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Roupret

Showing results (91-100 of 273) with videos related to

Pageof 28
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 15, 2008
[Can a standard treatment be proposed for penile cancer?]Jean-Nicolas Cornu, Eva Comperat, Raphaële Renard-Penna, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 15, 2025
Survival Without Reintervention of Second Artificial Urinary Sphincter Implants in Men: A National Healthcare Data System-Based Study in FranceElliot Tokarski, Yoann Taillé, Emmanuel Chartier-Kastler, et al.
Virchows Archiv : an International Journal of Pathology|February 12, 2013
Different subtypes of carcinoma in situ of the bladder do not have a different prognosisEva Compérat, Solene-Florence Jacquet, Justine Varinot, et al.
Urologia Internationalis|May 15, 2009
Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancerEva Compérat, Morgan Roupret, Pierre Conort, et al.
European Urology Oncology|May 16, 2024
Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial ProtocolPaul Sargos, Carine Bellera, Rita Bentahila, et al.
BJU International|July 25, 2013
Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre studyRomain Mathieu, Gregory Verhoest, Stéphane Droupy, et al.
BJU International|January 20, 2007
Relevance of the prostate-specific antigen (PSA) nanotest compared to the classical PSA test in the organized mass screening of prostate cancerAbdel-Rahmene Azzouzi, Stéphane Larre, Luc Cormier, et al.
World Journal of Urology|September 26, 2015
Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric studyRaphaële Renard-Penna, Morgan Roupret, Eva Compérat, et al.
European Urology Oncology|May 17, 2022
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and LimitationsPatrick J Hensley, Valeria Panebianco, Eugene Pietzak, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2019
Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patientsSara Philonenko, Pauline Rivière, Maxime Mallet, et al.
Pageof 28

Showing results (91-100 of 273) with videos related to

Sort By:
Pageof 28
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 15, 2008
[Can a standard treatment be proposed for penile cancer?]Jean-Nicolas Cornu, Eva Comperat, Raphaële Renard-Penna, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 15, 2025
Survival Without Reintervention of Second Artificial Urinary Sphincter Implants in Men: A National Healthcare Data System-Based Study in FranceElliot Tokarski, Yoann Taillé, Emmanuel Chartier-Kastler, et al.
Virchows Archiv : an International Journal of Pathology|February 12, 2013
Different subtypes of carcinoma in situ of the bladder do not have a different prognosisEva Compérat, Solene-Florence Jacquet, Justine Varinot, et al.
Urologia Internationalis|May 15, 2009
Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancerEva Compérat, Morgan Roupret, Pierre Conort, et al.
European Urology Oncology|May 16, 2024
Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial ProtocolPaul Sargos, Carine Bellera, Rita Bentahila, et al.
BJU International|July 25, 2013
Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre studyRomain Mathieu, Gregory Verhoest, Stéphane Droupy, et al.
BJU International|January 20, 2007
Relevance of the prostate-specific antigen (PSA) nanotest compared to the classical PSA test in the organized mass screening of prostate cancerAbdel-Rahmene Azzouzi, Stéphane Larre, Luc Cormier, et al.
World Journal of Urology|September 26, 2015
Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric studyRaphaële Renard-Penna, Morgan Roupret, Eva Compérat, et al.
European Urology Oncology|May 17, 2022
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and LimitationsPatrick J Hensley, Valeria Panebianco, Eugene Pietzak, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2019
Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patientsSara Philonenko, Pauline Rivière, Maxime Mallet, et al.
Pageof 28